PAREXEL International Corporation

Comments  |  
Share |


Website: N/A
Stock Symbol: NASDAQ: PRXL
Market Value: N/A (in millions)

PAREXEL is a leading bio/pharmaceutical services company, providing a broad range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. The Company’s primary objective is to provide solutions for managing the bio/pharmaceutical product lifecycle with the goal of reducing the time, risk, and cost associated with the development and commercialization of new therapies. Since its incorporation in 1983, PAREXEL has developed significant expertise in processes and technologies supporting this strategy.     

PAREXEL International Corporation Reviews and Stories

Have a good or bad story to share about working for PAREXEL International Corporation? Is PAREXEL International Corporation employing a policy or process that is driving you nuts? Post your anonymous review or share your experience.


Comments on PAREXEL International Corporation

No one has commented on this yet.


Would you like to Comment?

Login with your Employer Annoyer, AOL, Google, Yahoo!, Windows Live, Facebook, Twitter, or other OpenID account to post a comment.


PAREXEL International Corporation Rating

Are you a former or current employee? If so, rate them.
Work/Life Balance

Compensation & Benefits

Senior Leadership/Management

Equality & Respect

Career Potential/Growth

Policies & Work Environment

Based on 0 ratings



Bad Policies, Processes

Does your company have some rediculous policies or processes? Whether it's bathroom breaks only during certain times, crazy dress codes, living arrangements, or anything else, share your story.


Angry with a Company

Has a company sent you over the edge? Whether it's employment, customer service, products and services, or anything else, tell us your experience.
Links
About
Resources

Copyright © 2010. Employer Annoyer. All rights reserved.